| NCT Number | NCT06899750 |
| Lead Sponsor | Rush University Medical Center
Collaborators: Novartis Pharmaceuticals |
| Conditions | Hypertension |
| Enrollment | 200 participants |
| Start Date | 2025-02-10 |
| Primary Completion | 2026-10-01 (estimated) |
| Study Completion | 2026-10-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-18 |